<?xml version="1.0" encoding="UTF-8"?>
<p id="par0230">Neurotransmitter inhibitors including chlorpromazine (
 <bold>8</bold>), fluphenazine (
 <bold>29</bold>), and promethazine (
 <bold>30</bold>), were reported to inhibit cell-cell fusion in a moderate level with EC
 <sub>50</sub> values of about 23, 15, and 17 μM, respectively 
 <xref rid="bib0405" ref-type="bibr">[81]</xref>. Additionally, they disrupt clathrin-mediated endocytosis to inhibit MERS-CoV 
 <xref rid="bib0405" ref-type="bibr">[81]</xref>. An HIV entry inhibitor targeting gp41 (
 <bold>94</bold>, ADS-J1, 
 <xref rid="fig0065" ref-type="fig">Fig. 13</xref>) could inhibit more than 90% of MERS-CoV pseudovirus infection in NBL-7 and Huh-7 cells by interrupting the entry of pseudotyped MERS-CoV with an EC
 <sub>50</sub> of 0.6 μM in the DPP4-expressing cell line and with a CC
 <sub>50</sub> of 26.9 μM in NBL-7 and Huh-7 cells by MTT assay 
 <xref rid="bib0405" ref-type="bibr">[81]</xref>.
</p>
